Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +158.33% and +3.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?